SMC u-turn backs Roche’s Kadcyla for breast cancer

11th April 2017 Uncategorised 0

Women in Scotland will be among the first in the UK to have routine NHS access to Roche’s breast cancer drug Kadcyla after a landmark u-turn by cost regulators endorsed funding for the drug.

More: SMC u-turn backs Roche’s Kadcyla for breast cancer
Source: News